ArticleInfection and drug resistance2026
A Retrospective, Descriptive Analysis of MRSA Infections in a Low-Endemicity Region, Focusing on Empiric Treatment Adequacy.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previously, MRSA transmission and infections were mostly recognized as healthcare-associated. Community-associated MRSA (CA-MRSA) cases have become increasingly common, also in low-endemicity countries. Hence, also doctors in outpatient care encounter these patients. Despite increased general awareness on risk factors of MRSA carriage, it does not always influence clinical practice. As the total number of MRSA cases had increased in our region, it provoked us to analyze how this may have reflected the recognition of these infections and their empiric treatment adequacy in Hospital District of Southwest Finland (HDSWF). Methods: All new MRSA cases detected between 2007 and 2016 in Hospital District of Southwest Finland were retrospectively analyzed. This single-center study describes MRSA carriers, whose carriage was first detected from a clinical specimen. The cases were recognized from the hospital's MRSA registry, and their background data, including the antibiotic treatments given, were collected manually from electronic patient records. Results: A total of 280 MRSA cases having an active clinical infection were detected. Skin and soft tissue infections (SSTIs) were the most common infection type (76%; 213/280 cases). Information on antibiotic treatments were obtained in 46.8% (131/280) of the cases. In 81.7% (107/131) of the cases, the empiric treatment did not cover MRSA. After adjusting the treatment according to susceptibility results, MRSA was ultimately covered in 49.3% (68/138) of the cases. Conclusion: In low-endemicity settings, skin infections typically caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.